JB Pharma acquires cardiac brand from Glenmark for Rs 314 croreJB Pharma on Wednesday said it has acquired cardiac brand Razel (rosuvastatin) for India and Nepal region from Glenmark for Rs 314 crore in...
15 Dec, 2022, 12.52 AM IST
JB Pharma acquires rosuvastatin brand from Glenmark for Rs 314 croreThe acquisition will be funded through long term debt and internal accruals. Razel ranks among the top 10 brands in India in the rosuvastat...
14 Dec, 2022, 06.24 PM IST
Drug pricing regulator NPPA fixes retail prices of 84 drug formulationsSimilarly, the price of Paracetamol and Caffeine has been fixed at Rs 2.88 per tablet. Besides, the price of one Rosuvastatin Aspirin and C...
03 Jul, 2022, 03.28 PM IST
Cadila Healthcare gains on USFDA nod for memory loss drugThe group now has 252 approvals and has so far filed over 350 ANDAs since the commencement of the filing process in FY 2003-04.
05 Mar, 2019, 01.44 PM IST
NPPA fixes prices of 22 drug formulationsWhile National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 20 formulations, it has also capped the ceiling prices of...
13 Jun, 2018, 07.28 PM IST
Exports major contributor to API revenues: Sushil Suri, Morepen LabsThe second growth which is coming from in the domestic market is from home diagnostics.
02 May, 2017, 03.42 PM IST
How to cut your medicine billsIndia is one of the largest producers of generic drugs, which account for nearly 75% of the pharmaceuticals market.
14 Nov, 2016, 06.30 AM IST
Biocon posts 52% rise in net profit in Q2Expansion of its biologics footprint in emerging markets and licensing agreements boosted the revenue further, according to the company’s m...
20 Oct, 2016, 10.37 PM IST
Sun Pharma gets FDA nod for rosuvastatin calcium tabletsSun Pharma said: "One of its subsidiaries has received final approval from USFDA for its Abbreviated New Drug Application (ANDA) for generi...
20 Jul, 2016, 12.23 PM IST
Aurobindo Pharma gets FDA nod for rosuvastatin calcium tabsAurobindo Pharma has received final approval from the US health regulator USFDA for rosuvastatin calcium tablets, used in lowering choleste...
20 Jul, 2016, 11.34 AM IST
Glenmark gets FDA nod for rosuvastatin calcium tabletsQuoting IMS sales data for the 12 months to May 2016, Glenmark said Rosuvastatin calcium tablets achieved annual sales of around USD 6.78 b...
20 Jul, 2016, 11.19 AM IST
Europe approves Biocon's Rosuvastatin Calcium tabletsThe approval in the regulated markets marks an important milestone in Biocon's small molecules strategy of forward integration from APIs.
16 Feb, 2016, 04.35 AM IST
Sun-Ranbaxy combine to control over 40% market for 25 drugsFor nine drugs its market share will be more than 65% and in another 15 it will be 40-60%, revealed an analysis of the latest data.
14 Aug, 2014, 12.15 PM IST
Ind-Swift in stake sale talks with US companies to raise Rs 200 croreInd-Swift Laboratories is in talks with two leading US based firms for strategic stake sale to mop up Rs 200 crore, said sources.
30 Jul, 2014, 12.22 PM IST
- Ranbaxy labs gets Health Canada nod for cholesterol lowering drug
Ranbaxy Labs said it has received approval from the Health Canada to manufacture & mkt its generic RAN-Rosuvastatin tablets used for loweri...
31 Mar, 2012, 03.03 PM IST
- Aurobindo gets USFDA's tentative nod for Crestor
Aurobindo Pharma said it has received tentative approval of the USFDA for the generic version of Crestor tablets used in the cardiovascular...
13 May, 2010, 05.19 PM IST
- AstraZeneca India announces CRESTOR tablets launch
AstraZeneca India announced the launch of CRESTOR® (rosuvastatin) 5, 10, 20 and 40 mg tablets. CRESTOR® is indicated for use in the treatme...
16 Apr, 2009, 04.27 PM IST